1. |
WDR24 |
ENSGALG00000002450 |
81 |
7 |
- |
- |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
- |
1.000 |
WD repeat domain 24 [Source:NCBI gene;Acc:416406] |
2. |
SARM1 |
ENSGALG00000003595 |
15 |
0.873 |
- |
- |
- |
- |
- |
- |
0.873 |
- |
- |
- |
sterile alpha and TIR motif containing 1 [Source:HGNC Symbol;Acc:HGNC:17074] |
3. |
MISP |
|
52 |
0.837 |
- |
- |
- |
- |
- |
- |
0.837 |
- |
- |
- |
mitotic spindle positioning, transcript variant X2 |
4. |
ENSGALG00000024441 |
ENSGALG00000024441 |
66 |
0.777 |
- |
- |
0.777 |
- |
- |
- |
- |
- |
- |
- |
|
5. |
PPM1A |
ENSGALG00000011917 |
281 |
0.773 |
- |
- |
- |
- |
- |
- |
0.773 |
- |
- |
- |
protein phosphatase, Mg2+/Mn2+ dependent 1A [Source:HGNC Symbol;Acc:HGNC:9275] |
6. |
ENSGALG00000027427 |
ENSGALG00000027427 |
16 |
0.765 |
- |
- |
- |
- |
- |
- |
0.765 |
- |
- |
- |
|
7. |
MAP7D1 |
ENSGALG00000021634 |
457 |
0.762 |
- |
- |
- |
- |
- |
- |
- |
0.762 |
- |
- |
MAP7 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25514] |
8. |
ENSGALG00000006724 |
ENSGALG00000006724 |
74 |
0.76 |
- |
- |
- |
- |
- |
- |
- |
0.760 |
- |
- |
|
9. |
MCC |
ENSGALG00000000208 |
61 |
0.76 |
- |
- |
- |
- |
- |
- |
- |
0.760 |
- |
- |
MCC, WNT signaling pathway regulator [Source:HGNC Symbol;Acc:HGNC:6935] |
10. |
TNFSF10 |
ENSGALG00000009179 |
226 |
0.755 |
- |
- |
- |
- |
- |
- |
- |
0.755 |
- |
- |
tumor necrosis factor superfamily member 10 [Source:NCBI gene;Acc:378894] |
11. |
GMDS |
|
284 |
0.75 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.750 |
GDP-mannose 4,6-dehydratase, transcript variant X3 |
12. |
RC3H1 |
ENSGALG00000004587 |
40 |
0.748 |
- |
- |
0.748 |
- |
- |
- |
- |
- |
- |
- |
ring finger and CCCH-type domains 1 [Source:HGNC Symbol;Acc:HGNC:29434] |
13. |
ANKMY1 |
ENSGALG00000033920 |
12 |
0.744 |
- |
- |
0.744 |
- |
- |
- |
- |
- |
- |
- |
ankyrin repeat and MYND domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20987] |
14. |
IL1RAPL1 |
ENSGALG00000016288 |
102 |
0.744 |
- |
- |
- |
- |
- |
- |
0.744 |
- |
- |
- |
interleukin 1 receptor accessory protein like 1 [Source:HGNC Symbol;Acc:HGNC:5996] |
15. |
BTLA |
ENSGALG00000015398 |
34 |
0.738 |
- |
- |
- |
- |
- |
- |
0.738 |
- |
- |
- |
B and T lymphocyte associated, transcript variant X1 |
16. |
gga-mir-147 |
ENSGALG00000021910 |
83 |
0.737 |
- |
- |
- |
- |
- |
- |
- |
0.737 |
- |
- |
gga-mir-147 [Source:miRBase;Acc:MI0003696] |
17. |
AFF1 |
ENSGALG00000043935 |
34 |
0.731 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.731 |
AF4/FMR2 family member 1 [Source:HGNC Symbol;Acc:HGNC:7135] |
18. |
PAQR8 |
ENSGALG00000016675 |
85 |
0.73 |
- |
- |
- |
- |
- |
- |
0.730 |
- |
- |
- |
progestin and adipoQ receptor family member 8 [Source:NCBI gene;Acc:422042] |
19. |
MICAL3 |
ENSGALG00000013042 |
90 |
0.73 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.730 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 [Source:HGNC Symbol;Acc:HGNC:24694] |
20. |
FAM159A |
|
122 |
0.728 |
- |
- |
- |
- |
- |
- |
- |
0.728 |
- |
- |
family with sequence similarity 159 member A, transcript variant X2 |
21. |
NDST4 |
ENSGALG00000012015 |
43 |
0.725 |
- |
- |
- |
- |
- |
- |
0.725 |
- |
- |
- |
N-deacetylase and N-sulfotransferase 4 [Source:HGNC Symbol;Acc:HGNC:20779] |
22. |
RBBP8NL |
ENSGALG00000045938 |
89 |
0.724 |
- |
- |
- |
- |
- |
- |
0.724 |
- |
- |
- |
RBBP8 N-terminal like [Source:HGNC Symbol;Acc:HGNC:16144] |
23. |
YLPM1 |
|
671 |
0.723 |
- |
- |
- |
- |
- |
- |
- |
0.723 |
- |
- |
YLP motif containing 1 |
24. |
CCPG1 |
ENSGALG00000004387 |
205 |
0.722 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.722 |
dyslexia susceptibility 1 candidate 1 [Source:NCBI gene;Acc:415409] |
25. |
LRRC31 |
ENSGALG00000023616 |
55 |
0.717 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.717 |
leucine rich repeat containing 31 [Source:HGNC Symbol;Acc:HGNC:26261] |
26. |
SPATA7 |
ENSGALG00000010607 |
85 |
0.717 |
- |
- |
0.717 |
- |
- |
- |
- |
- |
- |
- |
spermatogenesis associated 7 [Source:HGNC Symbol;Acc:HGNC:20423] |
27. |
NCF2 |
ENSGALG00000004700 |
9 |
0.71 |
- |
- |
- |
0.710 |
- |
- |
- |
- |
- |
- |
neutrophil cytosolic factor 2 [Source:HGNC Symbol;Acc:HGNC:7661] |
28. |
LAPTM5 |
ENSGALG00000038636 |
18 |
0.71 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.710 |
lysosomal protein transmembrane 5 [Source:HGNC Symbol;Acc:HGNC:29612] |
29. |
LCMT2 |
ENSGALG00000017333 |
207 |
0.71 |
- |
- |
- |
- |
- |
- |
0.710 |
- |
- |
- |
leucine carboxyl methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:17558] |
30. |
ENSGALG00000014141 |
ENSGALG00000014141 |
3 |
0.71 |
- |
- |
- |
- |
- |
- |
0.710 |
- |
- |
- |
|
31. |
ETS2 |
ENSGALG00000016059 |
271 |
0.706 |
- |
- |
- |
- |
- |
- |
- |
0.706 |
- |
- |
ETS proto-oncogene 2, transcription factor [Source:NCBI gene;Acc:396250] |
32. |
GRPR |
ENSGALG00000027960 |
22 |
0.704 |
- |
- |
- |
- |
0.704 |
- |
- |
- |
- |
- |
gastrin releasing peptide receptor [Source:NCBI gene;Acc:378928] |
33. |
KLHL33 |
ENSGALG00000027742 |
18 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
kelch like family member 33, transcript variant X2 |
34. |
PLA2G4EL6 |
ENSGALG00000020458 |
4 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
phospholipase A2 group IVE-like 6 |
35. |
CPSF4L |
ENSGALG00000004441 |
4 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
cleavage and polyadenylation specific factor 4 like, transcript variant X2 |
36. |
ENSGALG00000025997 |
ENSGALG00000025997 |
1 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
|
37. |
LOC771085 |
ENSGALG00000016802 |
1 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
pinopsin-like, transcript variant X1 |
38. |
LOC425001 |
ENSGALG00000009468 |
7 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
uncharacterized LOC425001, transcript variant X2 |
39. |
ENSGALG00000028102 |
ENSGALG00000028102 |
8 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
|
40. |
ENSGALG00000022206 |
ENSGALG00000022206 |
2 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
|
41. |
ENSGALG00000011273 |
ENSGALG00000011273 |
9 |
0.701 |
- |
- |
0.701 |
- |
- |
- |
- |
- |
- |
- |
|